GLENMEDE TRUST CO NA - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 135 filers reported holding TRANSMEDICS GROUP INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q2 2023$292,8470.0%3,8670.0%0.00%0.0%
Q1 2023$292,847
-34.6%
3,867
-72.9%
0.00%
-33.3%
Q2 2022$448,000
-24.2%
14,249
-35.1%
0.00%0.0%
Q1 2022$591,000
+43.4%
21,955
+2.1%
0.00%
+50.0%
Q4 2021$412,000
-11.2%
21,505
+53.3%
0.00%0.0%
Q3 2021$464,00014,0260.00%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q2 2022
NameSharesValueWeighting ↓
Must Asset Management Inc. 94,202$5,168,86312.65%
Eagle Health Investments LP 414,205$22,677,7245.00%
Ophir Asset Management Pty Ltd 295,761$16,192,9153.82%
Sandhill Capital Partners LLC 732,610$40,110,4093.75%
First Light Asset Management, LLC 618,100$33,840,9753.21%
NEXT CENTURY GROWTH INVESTORS LLC 477,482$26,142,1392.84%
Bullseye Asset Management LLC 70,512$3,8612.15%
Kent Lake Capital LLC 100,000$5,475,0002.10%
Nicholas Investment Partners, LP 413,714$22,650,8421.69%
AtonRa Partners 12,287$672,7131.41%
View complete list of TRANSMEDICS GROUP INC shareholders